Supernus Pharmaceuticals Inc (SUPN)

Oct 16, 2025

Why Supernus Pharmaceuticals Inc. stock remains undervaluedJuly 2025 Update & Short-Term High Return Ideas - newser.com

Oct 16, 2025

Oct 16, 2025

What Supernus Pharmaceuticals (SUPN)'s Strong Qelbree and GOCOVRI Sales Surprise Means For Shareholders - Yahoo Finance

Oct 16, 2025

Oct 16, 2025

Zacks.com featured highlights include United Natural Foods, Teladoc Health, Supernus and BRP - The Globe and Mail

Oct 16, 2025

Oct 15, 2025

Is Supernus Pharmaceuticals Inc. stock near bottom after decline2025 Performance Recap & Stepwise Trade Execution Plans - newser.com

Oct 15, 2025

Oct 15, 2025

Is it time to cut losses on Supernus Pharmaceuticals Inc.Breakout Watch & Capital Efficient Trade Techniques - newser.com

Oct 15, 2025

Oct 13, 2025

Supernus Pharmaceuticals Inc Stock Analysis and ForecastGlobal Trade Effects & Set Your Capital Stop-Loss Limits Effectively - earlytimes.in

Oct 13, 2025

Oct 13, 2025

Supernus Pharmaceuticals Inc. (SUPN) Stock Price | Live Quotes & Charts | NSD - StocksToTrade

Oct 13, 2025

Oct 13, 2025

Supernus Pharmaceuticals (SUPN) Is Up 2.81% in One Week: What You Should Know - Yahoo Finance

Oct 13, 2025

Oct 13, 2025

Published on: 2025-10-13 06:52:20 - newser.com

Oct 13, 2025

Oct 13, 2025

What MACD signals say about Supernus Pharmaceuticals Inc.Wall Street Watch & Daily Stock Trend Watchlist - newser.com

Oct 13, 2025

Oct 12, 2025

Branded Pharmaceuticals Stocks Q2 Earnings Review: Supernus Pharmaceuticals (NASDAQ:SUPN) Shines - TradingView

Oct 12, 2025

Oct 11, 2025

Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run? - sharewise.com

Oct 11, 2025

Oct 10, 2025

Did Piper Sandler’s Upgrade on Onapgo Just Shift Supernus Pharmaceuticals' (SUPN) Investment Narrative? - Sahm

Oct 10, 2025

Oct 10, 2025

Supernus CEO Khattar sells $3m in shares By Investing.com - Investing.com Canada

Oct 10, 2025

Oct 10, 2025

Insider Sell Alert: NEWHALL CHARLES W III Sells 25,000 Shares of Supernus Pharmaceuticals Inc (SUPN) - GuruFocus

Oct 10, 2025

Oct 10, 2025

Supernus Pharmaceuticals Executives Sell Shares - TradingView

Oct 10, 2025

Oct 10, 2025

SUPN Crosses Above Average Analyst Target - Nasdaq

Oct 10, 2025

Oct 09, 2025

Supernus Pharmaceuticals Shares Rise After Piper Sandler Upgrade - MarketScreener

Oct 09, 2025

Oct 09, 2025

Supernus Pharmaceuticals: A Rising Pharma Contender? - StocksToTrade

Oct 09, 2025

Oct 09, 2025

Supernus Pharmaceuticals (SUPN) Stock Is Up, What You Need To Know - TradingView

Oct 09, 2025

Oct 09, 2025

SUPN: Piper Sandler Raises Price Target to $65 and Upgrades Rati - GuruFocus

Oct 09, 2025

Oct 09, 2025

Crowdstrike To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga

Oct 09, 2025

Oct 09, 2025

Piper Sandler Upgrades Supernus Pharmaceuticals to Overweight From Neutral, Adjusts Price Target to $65 From $40 - MarketScreener

Oct 09, 2025

Oct 09, 2025

Can Supernus Pharmaceuticals Inc. stock attract ESG capital inflowsJuly 2025 Big Picture & Weekly Market Pulse Updates - newser.com

Oct 09, 2025

Oct 09, 2025

How Supernus Pharmaceuticals Inc. stock performs during Fed tightening cycles2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com

Oct 09, 2025

Oct 09, 2025

Published on: 2025-10-09 05:01:01 - newser.com

Oct 09, 2025

Oct 09, 2025

Supernus (SUPN) Receives Upgraded Rating Amid Promising Product Outlook - GuruFocus

Oct 09, 2025

Oct 09, 2025

How to use Fibonacci retracement on Supernus Pharmaceuticals Inc.2025 Price Action Summary & Safe Entry Zone Tips - newser.com

Oct 09, 2025

Oct 09, 2025

Supernus Pharmaceuticals (SUPN): Exploring Valuation After Three-Month Share Price Surge - Sahm

Oct 09, 2025

Oct 09, 2025

Is now a turning point for Supernus Pharmaceuticals Inc.July 2025 Earnings & Real-Time Sentiment Analysis - newser.com

Oct 09, 2025

Oct 08, 2025

Supernus Pharmaceuticals Hits New 52-Week High of $49.66 - Markets Mojo

Oct 08, 2025

Oct 06, 2025

Will Supernus Pharmaceuticals Inc. rebound enough to break evenDollar Strength & Weekly Top Performers Watchlists - newser.com

Oct 06, 2025

Oct 06, 2025

How geopolitical tensions affect Supernus Pharmaceuticals Inc. stockCPI Data & Comprehensive Market Scan Insights - newser.com

Oct 06, 2025

Oct 06, 2025

Why Supernus Pharmaceuticals Inc. stock could be next big winnerJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com

Oct 06, 2025

Oct 06, 2025

Using R and stats models for Supernus Pharmaceuticals Inc. forecasting2025 Macro Impact & Reliable Volume Spike Trade Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

Is Supernus Pharmaceuticals Inc. stock poised for growthPortfolio Growth Summary & Real-Time Market Trend Scan - newser.com

Oct 06, 2025

Oct 05, 2025

Is Supernus Pharmaceuticals Inc. stock cheap compared to fundamentalsAnalyst Upgrade & Daily Stock Trend Reports - newser.com

Oct 05, 2025

Oct 05, 2025

Wall Street Zen Downgrades Supernus Pharmaceuticals (NASDAQ:SUPN) to Hold - Defense World

Oct 05, 2025

Oct 03, 2025

Smart tools for monitoring Supernus Pharmaceuticals Inc.’s price actionQuarterly Portfolio Review & High Conviction Buy Zone Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

Real time social sentiment graph for Supernus Pharmaceuticals Inc.Trade Volume Summary & Real-Time Buy Zone Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

Supernus Pharmaceuticals, Inc. $SUPN Shares Purchased by GAMMA Investing LLC - Defense World

Oct 03, 2025